Nymox Pharmaceutical Stock Quote NYMX - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nymox Pharmaceutical Corp (NYMX) Quote

Nymox Pharmaceutical Corp (NYMX)

0.20

0.00

(0.00%)

Closed September 20 4:00PM

Delayed by 15 minutes

0.20

0.00

( 0.00% )

Pre Market: 8:00PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

0.20

Bid

0.2003

Ask

0.2169

Volume

-

0.00 Day's Range 0.00

0.20 52 Week Range 0.20

Market Cap

Previous Close

0.20

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

90,515,000

Dividend Yield

-

PE Ratio

-2.75

Earnings Per Share (EPS)

-0.07

Revenue

-

Net Profit

-6.58M

Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.

Sector

Chemicals & Chem Preps, Nec

Industry

Chemicals & Chem Preps, Nec

Website

www.nymox.com

Headquarters

Nassau, Bhs

Founded

-

Nymox Pharmaceutical Corp is listed in the Chemicals & Chem Preps sector of the NASDAQ with ticker NYMX. The last closing price for Nymox Pharmaceutical was $0.20. Over the last year, Nymox Pharmaceutical shares have traded in a share price range of $ 0.20 to $ 0.20.

Nymox Pharmaceutical currently has 90,515,000 shares outstanding. The market capitalization of Nymox Pharmaceutical is $18.10 million. Nymox Pharmaceutical has a price to earnings ratio (PE ratio) of -2.75.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.2	0.2	0.2	0	0	CS
4	0	0	0.2	0.2	0.2	0	0	CS
12	0	0	0.2	0.2	0.2	0	0	CS
26	0	0	0.2	0.2	0.2	0	0	CS
52	0	0	0.2	0.2	0.2	0	0	CS
156	-1.84	-90.1960784314	2.04	2.15	0.1688	116366	0.7378202	CS
260	-1.86	-90.2912621359	2.06	4.9	0.1688	156103	1.68940714	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVVENuvve Holding Corporation	$ 7.70 (96.43%)	3.9M
SOXMTradr 2X Long SOXX Monthly ETF	$ 36.96 (58.98%)	52
NUKKNukkleus Inc	$ 0.3174 (49.36%)	17.54M
TGLTreasure Global Inc	$ 0.9119 (34.04%)	2.02M
LGHLWLion Group Holding Ltd	$ 0.008 (33.33%)	626
ZJYLJin Medical International Ltd	$ 3.14 (-23.04%)	38.55k
AACGATA Creativity Global	$ 0.40 (-21.61%)	1
SMXTSolarMax Technology Inc	$ 0.7029 (-19.75%)	214
ADTXAditxt Inc	$ 0.3101 (-18.95%)	75.85k
CJETChijet Motor Company Inc	$ 2.28 (-18.57%)	793
NUKKNukkleus Inc	$ 0.3174 (49.36%)	17.54M
LGCBLinkage Global Inc	$ 0.5381 (28.64%)	12.31M
MAXNMaxeon Solar Technologies Ltd	$ 0.0812 (-11.26%)	4.15M
NVVENuvve Holding Corporation	$ 7.70 (96.43%)	3.9M
GSIWGarden Stage Ltd	$ 1.68 (25.37%)	3.87M

Thomas@yahoo

Thomas@yahoo 4 minutes ago

https://www.mdpi.com/2227-9059/12/9/2084

https://rgsa.openaccesspublications.org/rgsa/article/view/8815

PonkenPlonken

PonkenPlonken 4 minutes ago

SOPA coming off a bottom

Number sleven

Number sleven 5 minutes ago

North, Pharmacy benefit managers are under some scrutiny at the moment. They control the prescription drug trade in our country. It is debatable if they actually benefit the consumer in any way. I'll see what I can find concerning how they negotiate with "manufacturers". I'm not sure what I'll find.

jetow

jetow 5 minutes ago

Yeah and to think this one is presently large enough for 8 times more production. How bad that is.

ssc

ssc 5 minutes ago

Got a list of "But they're all still working for ERHC" employees you state are still employed by erhc? Or is that just "speculation"?

I can help you get started.

Employee #1 is the person who answers the phone, promises to forward questions to erhc management who wil

ITYS

ITYS 5 minutes ago

Clowns are digging deep LOL
It was at .002 when clowns arrived and now just starting the upward climb as company SEC filings etc all come to fruition.

Some don't seem to grasp what real business developments look like :-)

TRANSPARENCY is key in OTC land

BIOChecker4

BIOChecker4 6 minutes ago

You’ve repeatedly and emphatically said HUGE NEWS this Thursday, September 26. Now you’re saying this week. Why the change?

mwab52

mwab52 7 minutes ago

Good morning (RNVA-Land & Team)........🤑😎.......Go (RNVA & Team)

Mark

Mark 7 minutes ago

$LGCB .54 hit .75 in early pm, see if it bases here for move higher, nice vol so far.

Thomas@yahoo

Thomas@yahoo 7 minutes ago

https://reason.org/policy-brief/a-framework-for-federal-and-state-hemp-derived-cannabinoid-regulation/

LetGoodTimesRoll

LetGoodTimesRoll 8 minutes ago

Controlling shareholder is.....

“We are delighted to enter into these transactions with FOXO,” said Seamus Lagan, the Chief Executive Officer of Rennova. “The two transactions have key tangible benefits to the Company. They will dramatically improve access to capital to facilitate gro

BLULLISH

BLULLISH 8 minutes ago

PENNYLAND EXPECTED SOON —>>>- PENNYLAND BOOOM-https://www.barchart.com/stocks/quotes/ICBU/opinion

$ICBU https://www.riizehealth.com/

BREAKOUT TO PENNYLAND COMING-https://www.tipranks.com/news/press-releases/imd-companies-inc-signs-letter-of-intent-to-acquire-healthcar

BLULLISH

BLULLISH 10 minutes ago

PENNYLAND EXPECTED SOON —>>>- PENNYLAND BOOOM-https://www.barchart.com/stocks/quotes/ICBU/opinion

$ICBU https://www.riizehealth.com/

BREAKOUT TO PENNYLAND COMING-https://www.tipranks.com/news/press-releases/imd-companies-inc-signs-letter-of-intent-to-acquire-healthcar

stockinspector

stockinspector 10 minutes ago

"Good things come to those who wait"..... I had always thought that meant that someone should be patient.
I now realize that it really means that impatient people will never fully appreciate "Good things"
when they do happen. I seem to learn something new every day..

SHEEPWOLF

SHEEPWOLF 10 minutes ago

$AGBA LIMITED SUPPLY OF SHARES🔥

#AGBA + #TRILLER MERGER IS A DONE DEAL.

awaiting NASDAQ regulatory approval for closing.
SHARE STRUCTURE WILL BE TIGHT!
CURRENT PRICE IS RIDICULOUSLY CHEAP!

https://youtu.be/fJDMXc6YuG4

SHEEPWOLF

SHEEPWOLF 10 minutes ago

$AGBA LIMITED SUPPLY OF SHARES🔥

#AGBA + #TRILLER MERGER IS A DONE DEAL.

awaiting NASDAQ regulatory approval for closing.
SHARE STRUCTURE WILL BE TIGHT!
CURRENT PRICE IS RIDICULOUSLY CHEAP!

https://youtu.be/fJDMXc6YuG4

Azart

Azart 12 minutes ago

You choose to play stupid, Well you win stupid prizes

reena969

reena969 12 minutes ago

I forgot to mention, however you should know, my "SCANNER/S" setting give me the early alerts. I wish all broker had the TOS feature where you can write your own script.

HoldEm777

HoldEm777 13 minutes ago

Not hardly. It’s on her real estate license. The crazy part is a guy named Steve Maher also shows up as a possible resident at the same address. Imagine that.
https://investorshub.advfn.com/uimage/uploads/2024/9/23/vrrrtCAF2100D-236F-4CB3-B121-5338D7590345.jpeg

HGilS

HGilS 15 minutes ago

Nasrat said it in the last cc. Our only limitation is the dea quotas. And our team does a wonderful job at extending the quotas.

sharkey1

sharkey1 15 minutes ago

I hope Kirko reads the board, I've sent him a lot of leads over the past year

Capt_Smith77

Capt_Smith77 16 minutes ago

But hey, at least the Co-founders and the rest of the staff get paid, while not one of them bothers to mess with insider purchases of their penny stock.

Shareholders have always taken a back seat with this company, and I don't see that changing anytime soon.

Nymox Pharmaceutical

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions